Cannabis Extract Composition for Sleep Disorder Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a continuing need for new treatments for sleep disorders derived from natural sources, as existing options may not adequately address the complexities of these conditions.
Innovation Solution
A pharmaceutical composition comprising a Cannabis extract, which includes a cannabinoid fraction primarily containing Δ9-Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Cannabinol (CBN), along with a terpene fraction featuring beta-myrcene, linalool, and nerolidol, is administered to patients to treat sleep disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If existing sleep disorder treatments are used, then sleep disorders can be treated to some extent, but they do not adequately address the complexities of these conditions and lack natural source derivation
Solution Approach 1:
The patent applies the composite materials principle by combining multiple cannabinoids (THC, CBD, CBN) with specific terpenes (beta-myrcene, linalool, nerolidol) in defined ratios to create a synergistic pharmaceutical composition. This composite approach addresses the complexity of sleep disorders by utilizing the combined effects of different compounds rather than a single substance, thereby improving treatment versatility and effectiveness for various sleep disorder conditions.
2Reliability
If Cannabis extract is administered to treat sleep disorders, then sleep quality improves and symptoms are reduced, but the composition must be precisely controlled to ensure safety and efficacy
Solution Approach 1:
The patent applies parameter changes by specifying precise concentration ranges for each cannabinoid (THC: 1-50mg, CBD: 0.1-10mg, CBN: 0.1-5mg) and terpenes (beta-myrcene: 0.1-5mg, linalool: 0.1-3mg, nerolidol: 0.1-2mg) in the pharmaceutical composition. This detailed parameter control ensures consistent efficacy and safety across different batches, addressing the need for reliable sleep quality improvement while maintaining manufacturing precision through defined compositional parameters.
Data Source
AI summary
The invention relates to a pharmaceutical composition comprising a Cannabis extract and optionally one or more pharmaceutically acceptable carriers, diluents, adjuvants, excipients or any combination thereof, the Cannabis extract comprising a cannabinoid fraction comprising Δ9-Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Cannabinol (CBN) and a terpene fraction in an amount of at least 3% by weight of the extract. The invention also relates to methods of treating sleep disorders using this pharmaceutical composition.